160 236

Cited 1 times in

Incorporating axillary-lateral thoracic vessel juncture dosimetric variables improves model for predicting lymphedema in patients with breast cancer: A validation analysis

Authors
 Jee Suk Chang  ;  Heejoo Ko  ;  Sang Hee Im  ;  Jin Sung Kim  ;  Hwa Kyung Byun  ;  Yong Bae Kim  ;  Wonguen Jung  ;  Goeun Park  ;  Hye Sun Lee  ;  Wonmo Sung  ;  Robert Olson  ;  Chae-Seon Hong  ;  Kyubo Kim 
Citation
 CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY, Vol.41 : 100629, 2023-04 
Journal Title
CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY
Issue Date
2023-04
Keywords
ALTJ ; Breast cancer ; Dose-volume histogram ; Lymphedema
Abstract
Background: A relationship between the axillary-lateral thoracic vessel juncture (ALTJ) dose and lymphedema rate has been reported in patients with breast cancer. The purpose of this study was to validate this relationship and explore whether incorporation of the ALTJ dose-distribution parameters improves the prediction model's accuracy. Methods: A total of 1,449 women with breast cancer who were treated with multimodal therapies from two institutions were analyzed. We categorized regional nodal irradiation (RNI) as limited RNI, which excluded level I/II, vs extensive RNI, which included level I/II. The ALTJ was delineated retrospectively, and dosimetric and clinical parameters were analyzed to determine the accuracy of predicting the development of lymphedema. Decision tree and random forest algorithms were used to construct the prediction models of the obtained dataset. We used Harrell's C-index to assess discrimination. Results: The median follow-up time was 77.3 months, and the 5-year lymphedema rate was 6.8 %. According to the decision tree analysis, the lowest lymphedema rate (5-year, 1.2 %) was observed in patients with ≤ six removed lymph nodes and ≤ 66 % ALTJ V35Gy. The highest lymphedema rate was observed in patients with > 15 removed lymph nodes and an ALTJ maximum dose (Dmax) of > 53 Gy (5-year, 71.4 %). Patients with > 15 removed lymph nodes and an ALTJ Dmax ≤ 53 Gy had the second highest rate (5-year, 21.5 %). All other patients had relatively minor differences, with a rate of 9.5 % at 5 years. Random forest analysis revealed that the model's C-index increased from 0.84 to 0.90 if dosimetric parameters were included instead of RNI (P <.001). Conclusion: The prognostic value of ALTJ for lymphedema was externally validated. The estimation of lymphedema risk based on individual dose-distribution parameters of the ALTJ seemed more reliable than that based on the conventional RNI field design. © 2023 The Author(s)
Files in This Item:
T202302872.pdf Download
DOI
10.1016/j.ctro.2023.100629
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Radiation Oncology (방사선종양학교실) > 1. Journal Papers
1. College of Medicine (의과대학) > Dept. of Rehabilitation Medicine (재활의학교실) > 1. Journal Papers
1. College of Medicine (의과대학) > Yonsei Biomedical Research Center (연세의생명연구원) > 1. Journal Papers
Yonsei Authors
Kim, Yong Bae(김용배) ORCID logo https://orcid.org/0000-0001-7573-6862
Kim, Jinsung(김진성) ORCID logo https://orcid.org/0000-0003-1415-6471
Park, Goeun(박고은)
Byun, Hwa Kyung(변화경) ORCID logo https://orcid.org/0000-0002-8964-6275
Lee, Hye Sun(이혜선) ORCID logo https://orcid.org/0000-0001-6328-6948
Im, Sang Hee(임상희) ORCID logo https://orcid.org/0000-0001-5128-5526
Chang, Jee Suk(장지석) ORCID logo https://orcid.org/0000-0001-7685-3382
Hong, Chae-Seon(홍채선) ORCID logo https://orcid.org/0000-0001-9120-6132
URI
https://ir.ymlib.yonsei.ac.kr/handle/22282913/194292
사서에게 알리기
  feedback

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse

Links